S&P 500 Futures
(0.18%) 4 567.50 points
Dow J Futures
(0.44%) 35 645 points
Nasdaq Futures
(0.22%) 16 059 points
Oil
(0.87%) $78.54
Gas
(0.89%) $2.83
Gold
(0.48%) $2 057.00
Silver
(-0.21%) $25.39
Platinum
(-0.02%) 941.20
USD/EUR
(0.51%) 0.916
USD/NOK
(0.62%) 10.72
USD/GBP
(0.42%) 0.791
USD/RUB
(0.09%) 88.66

Realtime updates for Sangui Biotech [SGBI]

Exchange: PNK Industry: Biotechnology
Last Updated27 Nov 2023 @ 11:54

0.00% $ 0.0029

Live Chart Being Loaded With Signals

Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products...

Stats
Today's Volume 100.00
Average Volume 3 043.00
Market Cap 608 716
EPS $-0.0009 ( 2022-12-30 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2022-06-30 Striepe Thomas Sell 0 Common Stock
2022-06-30 Schmelz Hubertus Sell 0 Common Stock
2021-10-13 Schmelz Hubertus Buy 1 200 000 Common Stock
2021-06-30 Schmelz Hubertus Sell 0 Common Stock
2021-06-30 Striepe Thomas Sell 0 Common Stock
INSIDER POWER
0.00
Last 71 transactions
Buy: 3 809 277 | Sell: 143 100

Sangui Biotech Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sangui Biotech Financials

Annual 2022
Revenue: $69 190.00
Gross Profit: $69 190.00 (100.00 %)
EPS: $0.0001
Q3 2023
Revenue: $18 697.00
Gross Profit: $18 697.00 (100.00 %)
EPS: $-0.0004
Q2 2023
Revenue: $10 627.00
Gross Profit: $10 627.00 (100.00 %)
EPS: $-0.0008
Q1 2023
Revenue: $41 029.00
Gross Profit: $41 029.00 (100.00 %)
EPS: $0.0003

Sangui Biotech

Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.

AboutLive Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators